Half full glass

You are here

Iproteos has raised more than 55,000€ through crowdfunding for the development of a new Schizophrenia treatment. It is the first time that the equity crowdfunding is used in a Spanish biotechnological project and results are, so far, very promising. Having overcome the halfway point of the campaign, Iproteos is determined to achieve the 100,000€ by the end of September. The collected funds will be set aside for the completion of the non-regulatory preclinical trials of a novel therapy for Schizophrenia, a devastating disease that affects around 24 million people in the world and is usually established around ages of 15 to 35 years, according to the World Health Organization. A detailed report of the project and the crowdfunding campaign can be found at: